28-7 Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.
Total raised: $80M
Founded date: 2016
Investors 3
| Date | Name | Website |
| 18.05.2023 | MPM Capita... | mpmcapital... |
| - | Sofinnova ... | sofinnovap... |
| - | BioImpact ... | bioimpactc... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 09.05.2019 | Series A | $15M | - | finsmes.co... |
| 06.09.2018 | Series A | $65M | - | finsmes.co... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 10.05.2019 | Term Sheet... | RINGING THE BELL Uber CEO Dar... | - | - | fortune.co... |
| 09.05.2019 | Twentyeigh... | Twentyeight-Seven Therapeutics... | USA | - | finsmes.co... |
| 07.09.2018 | Term Sheet... | THREE THINGS Good morning, Te... | - | - | fortune.co... |
| 06.09.2018 | 28-7 Thera... | Twentyeight-Seven Therapeutics... | Biotech | - | fiercebiot... |
| 06.09.2018 | 28-7 Thera... | Twentyeight-Seven Therapeutics... | Biotech | - | fiercebiot... |
| 06.09.2018 | Twentyeigh... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | citybizlis... |
| 06.09.2018 | Twentyeigh... | Twentyeight-Seven Therapeutics... | USA | - | finsmes.co... |